Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.
Mahavir ModiKavita ModyPramod JhawarLata SharmaMahesh Padukudru AnandGiriyanna GowdaManisha MendirattaSudhir KumarSandeep NayarManav ManchandaAruna Kumari BadamManoj SinghWaseem SiddiquiMaarten BeekmanPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2022)
Nearly one-fourth of patients with asthma in India were over-prescribed SABA. Educational programmes targeted at national and regional levels should be expanded to raise greater asthma awareness and encourage the adoption of guideline-directed asthma treatment plans among healthcare practitioners.